4//SEC Filing
Batlin Judy A 4
Accession 0001209191-09-020052
CIK 0001012140other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 7:53 PM ET
Size
7.4 KB
Accession
0001209191-09-020052
Insider Transaction Report
Form 4
Batlin Judy A
VP, Org Learning, Dvlpmnt & HR
Transactions
- Award
Common Stock
2009-03-31+4,000→ 12,999 total - Award
Stock Option (Right to Buy)
2009-03-31+28,000→ 28,000 totalExercise: $28.55Exp: 2019-03-31→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeother
Related Parties
1- filerCIK 0001447317
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 7:53 PM ET
- Size
- 7.4 KB